First lung cancer vaccine given to patient in international trial
A 67-year-old London man with lung cancer has been the first to receive a new cancer vaccine as part of an international trial. The early-stage research will test the immune therapy’s safety and whether it can be used together with existing cancer trea… Continue reading First lung cancer vaccine given to patient in international trial